-
New research suggests that roughly half of HIV patients might have some neurocognitive impairment, although most of this might be asymptomatic or mild.
-
African-American girls from low-income neighborhoods who have had childhood violence exposure are significantly more likely to engage in high-risk sexual activities, researchers found.
-
Field test results of an integrated microfluidic-based diagnostic device indicate that the potential
-
The Joint Commission's new National Patient Safety Goal (NPSG) on preventing indwelling catheter-associated urinary tract infections which emphasizes prompt removal of unnecessary devices and surveillance for CAUTIs is effective January 1, 2012 for hospitals.
-
The elements of performance for the CAUTI prevention safety goal are as follows:
-
The Joint Commission recently posted the following answer to a frequently asked question on screening for methicillin-resistant Staphylococcus aureus (MRSA).
-
On Aug. 10, 2011, the Food and Drug Administration (FDA) approved Complera, a fixed dose combination (FDC) drug product containing emtricitabine/rilpivirine/tenofovir DF (FTC/RPV/TDF) for the treatment of HIV. The recommended dose of Complera is one tablet, containing 200mg/25mg/300mg of FTC/RPV/TDF, once daily, taken orally with a meal.
-
It took polymerase chain reaction at least 30 years (by my reckoning) to evolve from its inception as a promising method for laboratory detection of infectious agents in patient samples to its widespread utilization in diagnostic clinical microbiology laboratories.
-
Unless you were bent on becoming a forensic entomologist as a kid, there is nothing worse than pulling back a bed sheet and finding ... maggots. Every so many years, I find an ICU patient, typically sedated and intubated, with fly larvae crawling out of some orifice or wound.
-
Clostridium difficile infection (CDI) is a serious medical condition associated with significant morbidity and mortality. Thirty-day mortality rates associated with CDI have been estimated to be anywhere from 6.0% to 32.5%, with higher mortality rates observed in older patients.
